Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-09

Clinical Trial Update: A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluated whether suppressive treatment with acyclovir reduces rapid HSV-2 reactivation in individuals with genital herpes; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACYCLOVIR (Acyclovir)

Snippet

Sponsor: University of Washington | Conditions: Genital Herpes | Phase 4 | Status: COMPLETED | Results posted: 2017-03-09